Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9AES
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,321
Award facts
- Contract value 100% obligated
- $14,320.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,320.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This non-competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, representing a specialty pharmaceutical product critical to military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a prime vendor for federal medical procurement across multiple therapeutic domains and product categories. The company's comprehensive contract vehicle enables it to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9AES?
SPE2DR26F9AES was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9AES worth?
The government has obligated $14,321 on SPE2DR26F9AES.
Is contract SPE2DR26F9AES an order under another contract?
Yes. SPE2DR26F9AES is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9AES competed?
The extent of competition for SPE2DR26F9AES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award